- Stock should move 50% either way By Adam TS http://www.thestreet.com/story/11257078/2/biotech-stock-mailbag-medivation-targacept.html
- Option flow says the same. option radar said the same
- Risk is that it delay the release
- Earning 11/1
Option flow:
- 10/26, 4500 X of Nov 22.5/35 call was bought for $2. Worth 1 millions
- 11/1, 3000X of bull reversal. Sold Dec 10 put for 1.45, Buy Dec 20/30 vert call for 2.95. At least 1 Mil
- 11/1, Bull reversal. 3000X 22.5 call/ 10 put Dec. for net $2.6. At least 1 million
- 11/2 2000x on 20/35 Call vertical for 4.2. 1 Million
- 11/2 4840X on 20/35 call for 4.2. 2 Million.
Entered a 20/30 Dec vertical. The plan is to sell 30/35 call spread to make a uneven butterfly for a little cost as possible. Earning tonight. If there is any hints of releasing the data, should make a run then it will be a good time to sell the call spread.
ReplyDeletecost for the vertical spread is 2.75
ReplyDeleteEnded up got it at 2.95
ReplyDeleteSold Dec 10/5 veritcal put spread for 1.1
ReplyDeleteNet cost for the combo is 1.85
$TRGT confirms first '5214 ph 3 data will report this month. (Results from flex dose "Renaissance 3" study)
ReplyDeleteRight to use Dec instead of Nov
ReplyDelete